EMAIL THIS PAGE TO A FRIEND

The Journal of biological chemistry

Human liver arylacetamide deacetylase. Molecular cloning of a novel esterase involved in the metabolic activation of arylamine carcinogens with high sequence similarity to hormone-sensitive lipase.


PMID 8063807

Abstract

Microsomal arylacetamide deacetylase (DAC) competes against the activity of cytosolic arylamine N-acetyltransferase, which catalyzes one of the initial biotransformation pathways for arylamine and heterocyclic amine carcinogens in many species and tissues. Activity determination and immunoblot analysis of DAC in human target tissues for arylamine carcinogens revealed that in extrahepatic tissues, additional enzymes are responsible for any deacetylation activity, whereas a single enzyme predominantly catalyzes this hydrolytic reaction in liver. We isolated and characterized a full-length cDNA from a human liver lambda gt11 library. This clone encodes an open reading frame of 400 amino acids with a deduced molecular mass of 45.7 kDa and contains two putative glycosylation sites. The 3'-untranslated region contains two putative polyadenylation signals. The cDNA was confirmed to be that for DAC in tryptic peptides from the purified human liver protein. Highest sequence similarity of DAC was found in a series of prokaryotic esterases encompassing the putative active site. Two extended regions of significant sequence homology with hormone-sensitive lipase and with lipase 2 from Moraxella TA144 were identified, whereas similarity to carboxyl esterases was restricted to the region encompassing the putative active site, indicating that DAC should be classified as esterase. This cDNA provides an important tool to study deacetylation and its effects on the metabolic activation of arylamine and heterocyclic amine carcinogens.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

HPA002911
Anti-AADAC antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
62287 Lipase A Candida antarctica, recombinant from Aspergillus oryzae, powder, beige, ~2 U/mg
L4777
Lipase acrylic resin, ≥5,000 U/g, recombinant, expressed in Aspergillus niger
62288 Lipase B Candida antarctica, recombinant from Aspergillus oryzae, powder, beige, ~9 U/mg
62301 Lipase from Aspergillus niger, powder (fine), ~200 U/g
L4277 Lipase from Aspergillus oryzae, ≥20,000 U/g
62285 Lipase from Aspergillus oryzae, lyophilized, powder, white, ~50 U/mg
75577 Lipase from Burkholderia sp., lyophilized powder, slightly beige, ~12 U/mg
02569 Lipase from Candida antarctica, lyophilized, powder, beige, ~0.3 U/mg
62302 Lipase from Candida rugosa, lyophilized, powder (fine), 15-25 U/mg
L1754 Lipase from Candida rugosa, Type VII, ≥700 unit/mg solid
62316 Lipase from Candida rugosa, powder, yellow-brown, ≥2 U/mg
L8525 Lipase from Candida rugosa, lyophilized powder, ≥40,000 units/mg protein
L3170
Lipase from Candida sp., recombinant, expressed in Aspergillus niger
L8906 Lipase from Mucor javanicus, lyophilized powder, ≥300 units/mg solid (using olive oil)
L9031 Lipase from Mucor miehei, lyophilized powder, ≥4,000 units/mg solid (using olive oil)
62298 Lipase from Mucor miehei, powder, slightly brown, ~1 U/mg
L0382 Lipase from porcine pancreas, Type VI-S, ≥20,000 units/mg protein, lyophilized powder
L3126 Lipase from porcine pancreas, Type II, 100-500 units/mg protein (using olive oil (30 min incubation)), 30-90 units/mg protein (using triacetin)
62309 Lipase from Pseudomonas cepacia, powder, light beige, ≥30 U/mg
28602 Lipase from Pseudomonas fluorescens, powder, slightly beige, ≥160 U/mg
L9518
Lipase from Pseudomonas sp., Type XIII, lyophilized powder, ≥15 units/mg solid
62310 Lipase from Rhizopus niveus, powder (fine), ≥1.5 U/mg
L3001 Lipase from wheat germ, Type I, lyophilized powder, 5-15 units/mg protein
62306 Lipase from wheat germ, ~0.1 U/mg
73940 Lipase immobilized from Candida antarctica, beads, slightly brown, >2 U/mg